Qilu Pharm Hainan Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QILU PHARM HAINAN, and what generic and branded alternatives to QILU PHARM HAINAN drugs are available?
QILU PHARM HAINAN has fourteen approved drugs.
Drugs and US Patents for Qilu Pharm Hainan
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Qilu Pharm Hainan | DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 215316-001 | Aug 24, 2021 | AP | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
Qilu Pharm Hainan | BORTEZOMIB | bortezomib | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 210824-001 | May 2, 2022 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Qilu Pharm Hainan | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 203380-003 | May 3, 2016 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Qilu Pharm Hainan | IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 212135-002 | Jun 21, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Qilu Pharm Hainan | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 205648-001 | Sep 19, 2018 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Qilu Pharm Hainan | PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 204890-002 | May 25, 2022 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Qilu Pharm Hainan | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | INJECTABLE;INJECTION | 203711-001 | Sep 8, 2014 | AP | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.